Literature DB >> 28043099

Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Soon-Hyun Ahn1, Hyun Jun Hong2, Soon Young Kwon3, Kee Hwan Kwon4, Jong-Lyel Roh5, Junsun Ryu6, Jun Hee Park7, Seung-Kuk Baek3, Guk Haeng Lee8, Sei Young Lee9, Jin Choon Lee10, Man Ki Chung11, Young Hoon Joo12, Yong Bae Ji13, Jeong Hun Hah1, Minsu Kwon14, Young Min Park15, Chang Myeon Song13, Sung-Chan Shin10, Chang Hwan Ryu6, Doh Young Lee3, Young Chan Lee16, Jae Won Chang17, Ha Min Jeong18, Jae-Keun Cho19, Wonjae Cha10, Byung Joon Chun20, Ik Joon Choi8, Hyo Geun Choi4, Kang Dae Lee21.   

Abstract

Korean Society of Thyroid-Head and Neck Surgery appointed a Task Force to develop clinical practice guidelines for the surgical treatment of laryngeal cancer. This Task Force conducted a systematic search of the EMBASE, MEDLINE, Cochrane Library, and KoreaMed databases to identify relevant articles, using search terms selected according to the key questions. Evidence-based recommendations were then created on the basis of these articles. An external expert review and Delphi questionnaire were applied to reach consensus regarding the recommendations. The resulting guidelines focus on the surgical treatment of laryngeal cancer with the assumption that surgery is the selected treatment modality after a multidisciplinary discussion in any context. These guidelines do not, therefore, address non-surgical treatment such as radiation therapy or chemotherapy. The committee developed 62 evidence-based recommendations in 32 categories intended to assist clinicians during management of patients with laryngeal cancer and patients with laryngeal cancer, and counselors and health policy-makers.

Entities:  

Keywords:  Glottis; Laryngeal Neoplasms; Practice Guideline; Supraglottis; Surgery

Year:  2017        PMID: 28043099      PMCID: PMC5327593          DOI: 10.21053/ceo.2016.01389

Source DB:  PubMed          Journal:  Clin Exp Otorhinolaryngol        ISSN: 1976-8710            Impact factor:   3.372


  521 in total

1.  CO2-laser treatment of recurrent glottic carcinoma.

Authors:  H H de Gier; P P Knegt; M F de Boer; C A Meeuwis; L A van der Velden; J D Kerrebijn
Journal:  Head Neck       Date:  2001-03       Impact factor: 3.147

2.  Evaluation of risk factors for stomal recurrence after total laryngectomy.

Authors:  J Yotakis; S Davris; T Kontozoglou; G Adamopoulos
Journal:  Clin Otolaryngol Allied Sci       Date:  1996-04

3.  Risk factors of tracheostomal recurrence after laryngectomy for laryngeal carcinoma.

Authors:  A P Yuen; W I Wei; W K Ho; Y Hui
Journal:  Am J Surg       Date:  1996-09       Impact factor: 2.565

4.  Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer.

Authors:  K S Virgo; R C Paniello; F E Johnson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-05

Review 5.  European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer.

Authors:  Ricard Simo; Patrick Bradley; Dominique Chevalier; Frederik Dikkers; Hans Eckel; Nayla Matar; Giorgio Peretti; Cesare Piazza; Mark Remacle; Miquel Quer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-09       Impact factor: 2.503

6.  Residual carcinoma of the larynx.

Authors:  J H Brandenburg; S W Rutter
Journal:  Laryngoscope       Date:  1977-02       Impact factor: 3.325

7.  Supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) in the management of laryngeal carcinoma: oncologic results. A 35-year experience.

Authors:  C Page; G Mortuaire; F Mouawad; O Ganry; J Darras; X Pasquesoone; D Chevalier
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-04       Impact factor: 2.503

8.  Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management.

Authors:  Arie Gordin; Marcello Daitzchman; Ilana Doweck; Nikolay Yefremov; Avishay Golz; Zohar Keidar; Rachel Bar-Shalom; Abraham Kuten; Ora Israel
Journal:  Laryngoscope       Date:  2006-02       Impact factor: 3.325

9.  Prospective case-control study of efficacy of bilateral selective neck dissection in primary surgical treatment of supraglottic laryngeal cancers with clinically negative cervical findings (N0).

Authors:  V Djordjevic; B Bukurov; N Arsovic; M Dimitrijevic; S Jesic; V Nesic; Z Petrovic
Journal:  Clin Otolaryngol       Date:  2016-02-11       Impact factor: 2.597

10.  Indirect fluorescence laryngoscopy in the diagnosis of precancerous and cancerous laryngeal lesions.

Authors:  C Arens; D Reussner; J Woenkhaus; A Leunig; C S Betz; H Glanz
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-10       Impact factor: 3.236

View more
  10 in total

1.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Young-Hoon Joo; Jae-Keun Cho; Bon Seok Koo; Minsu Kwon; Seong Keun Kwon; Soon Young Kwon; Min-Su Kim; Jeong Kyu Kim; Heejin Kim; Innchul Nam; Jong-Lyel Roh; Young Min Park; Il-Seok Park; Jung Je Park; Sung-Chan Shin; Soon-Hyun Ahn; Seongjun Won; Chang Hwan Ryu; Tae Mi Yoon; Giljoon Lee; Doh Young Lee; Myung-Chul Lee; Joon Kyoo Lee; Jin Choon Lee; Jae-Yol Lim; Jae Won Chang; Jeon Yeob Jang; Man Ki Chung; Yuh-Seok Jung; Jae-Gu Cho; Yoon Seok Choi; Jeong-Seok Choi; Guk Haeng Lee; Phil-Sang Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-02       Impact factor: 3.372

2.  Metastatic lymph node burden predictive of survival in patients undergoing primary surgery for laryngeal and hypopharyngeal cancer.

Authors:  Yeonjoo Choi; Manal Bin-Manie; Jong-Lyel Roh; Kyung-Ja Cho; Yoon Se Lee; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-07-27       Impact factor: 4.553

3.  Assessment of Occult Nodal Micrometastases to the Clinically Negative Contralateral Neck in Locally Advanced Supraglottic Squamous Cell Carcinoma.

Authors:  Ahmad Mohamed Eltelety; Mohamed Aly Abou-Zeid; Mena Esmat Abdelmalek; Ahmed Amin Nassar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-08-17

4.  Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches.

Authors:  Hung-Jin Huang; Olga A Kraevaya; Ilya I Voronov; Pavel A Troshin; Shan-Hui Hsu
Journal:  Int J Nanomedicine       Date:  2020-04-14

5.  Dual-time-point PET/CT study protocol can improve the larynx cancer diagnosis.

Authors:  Agata Karolina Pietrzak; Joanna Kazmierska; Andrzej Marszalek; Pawel Golusinski; Aleksandra Heydrych; Katarzyna Wiechec; Witold Cholewinski
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-28

6.  The voice quality after laser surgery versus radiotherapy of T1a glottic carcinoma: systematic review and meta-analysis.

Authors:  Guanjiang Huang; Mengsi Luo; Jingxuan Zhang; Hongbing Liu
Journal:  Onco Targets Ther       Date:  2017-05-03       Impact factor: 4.147

7.  Effect of comprehensive nursing intervention in preventing postoperative pain, complications, and psychological pressure in the otolaryngology department.

Authors:  Rong-Lan Luan; Ming-Xia Zhu; Hai-Yan Sun
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

8.  Laryngopharyngeal Reflux Alters Macrophage Polarization in Human Papilloma Virus-Negative Squamous Cell Carcinoma of the Larynx in Males.

Authors:  Dmytro Zabolotnyi; Yaroslav Kizim; Diana Zabolotna; Oksana Sulaieva; Volodymyr Kizim
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-09-11       Impact factor: 3.372

9.  Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis.

Authors:  Bo Hae Kim; Sung Joon Park; Woo-Jin Jeong; Soon-Hyun Ahn
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-02-22       Impact factor: 3.372

10.  Prognostic importance of harvested lymph node number, metastatic lymph node number, and lymph node ratio in surgically managed laryngeal squamous cell carcinoma.

Authors:  Mehmet Akif Abakay; Selçuk Güneş; Filiz Gülüstan
Journal:  Braz J Otorhinolaryngol       Date:  2020-09-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.